Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel metal-free one-pot synthesis for pyrimidoindazole compounds. This patent offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Efficient carbonylation method for N-aryl amides using aryl boronic acids. Reduces harsh conditions, offering cost-effective manufacturing for pharmaceutical intermediates.
Novel base-free alkylation process for Indacaterol Maleate achieving 93% yield. Reduces regioisomers and ensures supply chain stability for respiratory API manufacturing.
Novel patent CN115703691B details safer synthesis for isotope standards. Reduces toxicity and cost for pharma intermediate supply chains.
Discover a novel, catalyst-free synthesis of N-nitrosamines using sulfonyl fluoride. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with this green technology.
Patent CN112961086A introduces a novel rhodium-catalyzed one-step synthesis method for high-purity pharmaceutical intermediates with significant cost reduction potential through streamlined manufacturing processes.
Novel one-pot Lewis acid catalysis achieves >90% yield for indaneamine, enabling sustainable agrochemical manufacturing with reduced waste and reliable supply chain solutions.
Breakthrough carbonylation method achieves high-purity amides under mild conditions without inert gas protection, enhancing supply chain reliability and cost efficiency for pharma intermediates.
Patent CN112939780B enables efficient indanone synthesis with high functional group tolerance ensuring scalable production of high-purity pharmaceutical intermediates with reduced environmental impact
Novel chiral quaternary ammonium salt catalyst enables asymmetric alkylation with superior stereoselectivity while reducing lead time and production costs for pharmaceutical intermediates.
Novel visible-light catalyzed synthesis of 3-aryl-2H-indazoles enables high-purity pharmaceutical intermediates with reduced manufacturing costs and faster scale-up.
Solve low-yield C-H activation challenges with 94% yield & 92% ee. Scale to 100MT/yr with no byproducts. Contact for COA/MSDS.
Overcome chiral resolution challenges in Niraparib manufacturing. New metal-free synthesis achieves 97.51% purity with 26.75% overall yield. Reduce equipment costs and supply chain risks.
Discover how visible light-induced, metal-free synthesis of 3-aryl-2H-indazoles reduces production costs and safety risks. Ideal for API manufacturing and drug development.
Solve indanone synthesis challenges with high-yield, functional group-tolerant rhodium-catalyzed method. Reduce costs and supply chain risks for API production.
Solve lenvatinib impurity challenges with 98% purity, 80% yield. Our CDMO expertise ensures stable supply for pharma quality control.
Discover a safer, cost-effective cinacalcet hydrochloride synthesis method with >99.7% purity. Eliminate toxic reagents and scale up reliably for your drug development.
Solve multi-step synthesis challenges with high-yield, one-pot 2-methylene-1-indanone production. Reduce costs and supply risks for API development.